Loading...
Trexall, Otrexup, Rasuvo
Antineoplastic • Antimetabolite / DMARD
Inhibits dihydrofolate reductase, blocking DNA and RNA synthesis
Drug Class
Antineoplastic
Subclass
Antimetabolite / DMARD
Half-life
3-10 hours (dose-dependent)
Time for plasma concentration to decrease by 50%
Protein Binding
50%
Fraction bound to plasma proteins
Therapeutic Index
Narrow
Margin between therapeutic and toxic doses